Larger studies are needed to evaluate the relationship between EACA and total RBC requirements.
需要更大规模的研究，以评估EACA和红细胞总需要量的关系。
EACA may be considered for patients undergoing major spinal surgery.
对于进行脊柱大手术的患者，可考虑使用EACA。
The number of studies evaluating the efficacy of EACA in adult patients undergoing spinal surgery remains scarce and limited. METHODS.
目前评价EACA对脊柱外科成人患者疗效的研究仍然较少且有一定局限。
Mean intensive care unit length of stay was decreased EACA: 1.8 days vs.
ICU平均停留时间缩短（EACA：1.8天，安慰剂 2.8天，P = 0.04）。
EACA (100 mg/kg) or placebo was administered to 182 adult patients after the induction of anesthesia followed by an infusion that was continued for 8 hours after surgery.
182名成人患者诱导麻醉后给予EACA（100mg/kg）或安慰剂，手术后持续输注8小时。
In the second part, EACA was found to inhibit prourokinase catalyzed plasminogen activation. To analyze this inhibitory, the three reactions were individually studied. It was found that in the presence of 2.0mM EACA, plasminogen activation by the intrinsic activity of prourokinase and that by urokinase were promoted by 6 and 4.5-fold, respectively.
我们发现EACA抑制尿激酶原对纤溶酶原的激活，为了解释这一现象及阐明上述反应体系的限速步骤，我们研究了EACA对每步反应的作用，结果表明尿激酶原单链酶活性及双链尿激酶催化的纤溶酶原形成纤溶酶的反应分别被EACA抑制6和4.5倍。
8 Days placebo; P = 0.04. The incidence of thromboembolic complications was similar 2.2% EACA vs.
血栓栓塞并发症的发生率相似（EACA 2.2％，安慰剂6.6％，P = 0.15）。
Objective: The present preliminary study was designed to investigate the hemostatic effect of aprotinin, tranexamic acid (TA) and ε - aminocaproic acid (EACA) in off-pump coronary artery bypass (OPCAB).
目的：评估抗纤溶药物包括抑肽酶、6-氨基已酸和氨甲环酸在非体外循环冠脉搭桥术（OPCAB）中的血液保护作用。
In order to improve its ability of solving the continuous optimization problems, evolutionary strategy (ES) was taken to modify ACA, and the evolutionary ant colony algorithm (EACA) proposed.
为提高其解决连续优化问题的能力，拓宽应用范围，引入带可变邻域搜索项的进化策略对其进行改进，进而提出进化蚁群算法。
EACA is effective in reducing postoperative blood loss and blood transfusion through inhibition of the activation of fibrinolytic system.
氨基己酸可抑制CPB引起的纤溶系统激活，减少术后出血和输库血量。
Postoperative blood loss was similar between the EACA group and the control. Influence of Epsilon-aminocaproic Acid and Aprotinin on Protection of Platelet and Inflammation in Cardiopulmonary Bypass
6-氨基已酸和抑肽酶在体外循环中对血小板保护和炎症反应的作用
[Objective] To investigate the hemostasia effect, the influence to the renal function and the possibility thromboembolism of epsilon-aminocaproic acid (EACA) for patients undergoing prosthetic valve replacement.
目的：了解体外循环手术时预防性使用6氨基己酸是否能和抑肽酶一样有效地减少心脏瓣膜置换手术患者术后出血；观察6氨基己酸是否可能导致这些患者血栓形成以及可能对肾脏功能的不利影响。
Conclusions Intravesical instillation of antifibrinolytic agent EACA or PAMBA can enhance BCG attachment to bladder wall while fibrinolytic agent heparin inhibit it. This means the former may enhance BCG antineoplastic effect.
结论膀胱内灌注纤维蛋白溶解抑制剂可增强BCG与膀胱壁的结合力，而纤溶促进剂肝素则作用相反，提示前者可提高BCG的抗肿瘤疗效。